Archive for the 'Big Pharma' Category

Where the Hell Are We?

Posted in Money Matters, Health, wordpress, disclosure, ethics, sports, Baseball, Big Pharma, Legislation on April 9th, 2010 by Stanford Matthews

Nothing like being in the right mood to publish a post on what can only be described as stupid. A baseball game just ended. It should have been one for the win column for what should be MY team… the Milwaukee Brewers. After leading since the third inning a pinch hitter for the Cards smacked a two run homer in ninth and the Brew crew went down in order in the bottom of the ninth. This is not an uncommon event for the team from brew town.

To add insult to injury a fitting annoyance was observed at a sports site while preparing this post. Wanting to represent the games’ chronology accurately a peak at the stats was in order. On arrival at the site a big picture of T Woods was presented with the title ‘destyiny of a champion.’ Excuse me while I throw up. The Masters is in session and this occasional viewer will neither watch it or the network, CBS, airing it. The whole scenario from Tiger’s dishonesty to his tabloid ’secret’ lifestyle and the public’s eagerness to ‘forgive’ (as well as his wife’s) strike me as shameless AND stupid.

Enter the original focus of this post…. healthcare. Yup, Obama won a coup d’eta with his Obamacare and while attempting to destroy the American health system he moved on quickly to doing same with our national defense and security. But some events in healthcare and reports about it are the real subject of this post. The rest was just a fun way to start this.

First, there is a report on clinical trials. The initial premise describes a situation where trials are stopped short of completion due to better than expected results. It further suggests those results are flawed.

A new international analysis of 100 clinical trials that ended early found that the results were often wrong and sometimes life-threatening.

If this doesn’t remind you of the AGW scam it should. It is as if we have been time warped back to the Dark Ages. How long will it be until we reach the age of enlightenment? Seriously folks, it really doesn’t matter whether the stupidity is the result of intentional deception or not having a clue. The outcome is not better either way.

The second report in this group features another curious announcement.

Thirteen lawmakers have sent a letter to USAID about leishmaniasis, sleeping sickness, Chagas disease and Buruli ulcer, which are in the group referred to as “neglected diseases.”

I’m sorry. Neglect is not the real problem with curing disease. This is not the first time this thought has been expressed on this blog. Given Big Pharma, a sector of the economy producing drugs, their billions in sales would be at risk if diseases were regularly eliminated by finding cures. Likewise, researchers and others who earn a living ’searching for cures’ would be out of a job (and income) if they solved the problem.

How about you don’t get another dime until you cure something?

Then there’s a report about the need for more minority doctors to serve minority patients. At first glance the proposition seems innocent enough. But after further review stupidity is observed revealing the nonsense.

“What happens with the health outcome, depends upon good communication, the trust and credibility between the health professional and the individual seeking care, and an understanding of the patient’s culture, value system, so that one can develop, hopefully, a strong relationship or interaction between the health professional and the individual,” Dr. Sullivan explained.

While living in an area liberals would define as ‘diverse’ a successful doctor once expressed a simple yet intelligent formula for dealing with patients. The doctor was white and many of his patients were not. He held that effective communication with one’s patients did much of your diagnostic work for you. Letting them speak, listening and asking the right questions provided the necessary information to solve the health problem(s).

Please, let’s not suggest that successful outcomes in medicine require the doctor and the patient to possess a shared cultural or demographic heritage.

Two reports for this post remain although there certainly are more to review. The first of these two is absolutely priceless. So is pursuing the sort of reasoning it describes. Which may help understand some of the reasons why healthcare costs continue to rise so fast. Stupidity.

To be prepared, firefighters and paramedics practice regularly. On this day, they are practicing with special equipment designed to accommodate overweight patients.

The details about the equipment are what make this report ’stupid.’ For those not fond of the metric system, if memory serves, kilograms are converted to pounds by multiplying the number of kg’s by 2.2.

This stretcher, ramp and winch system can load a patient weighing up to 680 kilograms into an ambulance.

680 x 2.2 = just under fifteen hundred pounds (1,496 lbs). You don’t need an explanation do you?

The last report is a repeat of some from the past. Caesarean Deliveries at All-Time High in US may indicate a trend in unnecessary procedures. All of these reports feature a serious case of stupid.

If you disagree, sound off. It appears there is much evidence to suggest the human species is mired in stupidity. Are we all in decline based on our recent collective performance. Has someone spiked the water? What’s the deal?

Stanford Matthews
MoreWhat.com

A Lure for Those with High Risk Behavior

Posted in Health, Education, wordpress, News Media, disclosure, ethics, Safety, Public, Opinion, Big Pharma on March 4th, 2009 by Stanford Matthews

This may or may not be a new story. The topic is something that is not a focus on this blog. Well at least not specifically. Unreasonable risk is an idea often incorporated into the subject matter typically featured here. A headline appeared on the radar today that screamed blog post target. It was not an OMG moment. At least not as it would be for those who practice high risk behavior or lifestyles who undoubtedly will view this headline as their savior and reason to continue being stupid.

New Vaginal Gel Stops AIDS Virus
WebMD - ?29 minutes ago?
By Daniel J. DeNoon March 4, 2009 — A new kind of vaginal gel prevents sexual transmission of the AIDS virus in monkey studies. The anti-HIV ingredient in the gel is glycerol monolaurate or GML. It’s already FDA approved as an ingredient in cosmetics …

Adam and EveThere ya go. Feast your eyes on sexual nirvana. Nearly guarantees an increase in the number of HIV/AIDS cases for the remainder of 2009 and beyond. Why you ask? With the exception of those who have not contracted aids through any fault of their own as in rape victims, blood transfusions or other involuntary exposure those whose life choices make them targets for this virus will be dumb enough to believe the battle was won. As if their previous choices were not evidence enough they will likely die from doing something stupid the introduction of the report alone without the product will subject their dense learning curve to more mistakes than before.

The headlines and reporting are not necessarily helpful either. The title above is a great example. If the risk candidates can read they may omit further investigation and take the title to mean the war is won. Here are some more links.

Aids gel could save millions of women’s lives a year, say scientists
Daily Mail - ?1 hour ago?
By Daily Mail Reporter A cheap ingredient used in ice cream and cosmetics could be used as a gel to protect women against Aids, researchers reported today. The compound, called glycerol monolaurate, or GML, is found in breast milk. …

Another dumb title, above, gives further suggestion the gel and everything about it is a done deal. Just go out and get some then hump like rabbits. Sorry rabbits, you probably are more discerning than the typical high risk human.

Gel Can Save Women from Aids
SmartAboutHealth - ?1 hour ago?
According to a recent study, an ingredient used in ice cream and cosmetics could be used to protect women against Aids. The gel, called alled glycerol monolaurate, or GML, is found in breast milk and test recently found that it protects monkeys against …

The item above from SmartAboutHealth is an oxymoron. Smart about health? Not with that title.
turkeys
There are titles and content out there which take a more intelligent approach to the story. Those of you at low risk for aids are smart enough to find it for yourself. Those of you dumb enough to be high risk for AIDS at this point in its history are not smart enough to read this. The scourge of AIDS will get you soon enough and that will help clean up the gene pool. Thought ever cross your mind that this is nature’s way of doing that in the first place?

Stanford Matthews
MoreWhat.com

A-Fraud: Baseball’s Shining Example

Posted in wordpress, conspiracy, disclosure, ethics, oversight, sports, Baseball, Big Pharma on February 7th, 2009 by Stanford Matthews

Two things right out of the gate with the story that A-Rod, A-fraud, Anabolic-Rod is the latest casualty of greed and selfish ambitions in the sports world. As the first reference below suggests it’s Christmas for Yankee haters understand that is error one. Concluding that those who dislike the Yankees stand to gain pleasure from this story misses the point. That most let such offenses slide is again the sad statement. Error two is that he should think of Yankees before himself due to a public relations nightmare. When will this nonsense be judged for what it is?

baseballAthletes who use drugs in general is bad enough. But when performance enhancing drugs are used to alter the outcome of competitive sporting events the definition seldom used and focused on is fraud. It is the same with Barry Bonds and the home run record. If you cheat there is no record breaking event. The lame debate on whether the Barry Bonds’ record should stand or have an asterisk placed next to it in the record books is deranged.

Anyone who uses performance enhancing drugs in sports should be banned forever and have all evidence of their history in sport designated as the fraud it is.

As for what to do about these matters no one seems to care enough to see the obvious. Damage control or public relations or fixing the taint to rescue the bottom line is not the answer. Continuing to allow revelations of bad behavior to be corrected with a new coat of paint just makes matters worse. The new rule should be as it once was, one and done. If you violate laws or codes of conduct or rules of the game let the punishment fit the crime. Performance enhancing drug use should be one and done and records purged, end of story.

Stanford Matthews
MoreWhat.com

ANALYSIS: It’s Christmas Morning For Yankee Haters

If A-Rod Did Indeed Cheat, He Must Think Of Yankees Before Himself Or 2009 Will Be Public Relations Nightmare
Feb 7, 2009 3:30 pm US/Eastern
By JEFF CAPELLINI, WCBSTV.com Senior Sports Producer

NEW YORK (CBS) — The legend of “A-Fraud” grows

Joe Torre took a lot of heat last week over excerpts from his new book. Among the myriad of skeletons he exorcised from the Yankees closet, he said the idea that Alex Rodriguez may not be the most genuine soul in the world had always been a running joke inside the Yankees locker room.

Well, it looks now like A-Rod’s words and actions are going to have to be good for more than just his teammates. With Saturday’s bombshell CNN/SI report that Rodriguez tested positive for steroids back in 2003, he now finds himself in the unenviable position of having to choose his words carefully because if indeed failed that test what he says next will go a long way toward determining if the rest of baseball – and the sports world for that matter – will be as forgiving with him as they were with players like Jason Giambi and Andy Pettitte.

A-Rod, baseball’s great hope, now tainted himself

by Mark Kriegel
Updated: February 7, 2009, 4:41 PM EST

Even by the standards of this tawdry, tabloid culture, a man who seeks solace in kaballah, Madonna and methenolone has hit some sort of imaginary trifecta.

I have taken pride and pleasure in my armchair analysis of Alex Rodriguez. He is all I could want in a subject: insecure, impressionable, narcissistic, and give the guy his due, above all, talented. That talent is now tainted, of course. And you can all but hear a certain tattooed celebrity boxer saying, I told you so…

Only A-Rod — lightning rod, it now occurs, would be a better nickname — could again elevate Jose Canseco to sage status.

Still, the news that Rodriguez tested positive for steroids in 2003 — one of his several MVP seasons — is not to be greeted with a sense of hilarity. Rather, he has tampered with history.

Whatever else A-Rod was, or is, he represented a chance to rescue American sports’ most sacred individual record. No more, though.

A-Rod Tarnishes Yankee Legacy with Steroid Controversy

by Tomer Talmy

Another dark day in the history of the Yankees, the greatest franchise in the history of team sports.

Since October of 2003, the Yankee ship has been sinking into the dark waters of the Hudson River. After losing the World Series in 2003 to the Marlins, it seemed like a great run in the Bronx was finally over. On February 15, 2004, the Rangers traded Rodriguez to the New York Yankees for second baseman Alfonso Soriano and it seemed like the Yankees were bound to make another run at the title in 2004.

Them, a new face showed up in town. The greatest talent to ever take the baseball field, and he went by the name of Alex Rodriguez. A-Rod was the best all around player in the game and he made the move from shortstop to third base just to fit the Yankee need in hope for a championship ring.

US Pledges to Help India Improve Food and Drug Safety Standards

Posted in Money Matters, Health, wordpress, News Media, disclosure, ethics, oversight, China, India, Food, Safety, Public, Business, Big Pharma on January 13th, 2008 by Stanford Matthews

Here’s a report on India about food and medicine safety. With all the offshore manufacturing from the US and the string of safety problems with products from China it seems there is a need to spend money on fixing safety issues in the country’s where American goods are now produced and sold back to American consumers. The businesses save money on labor, the offshore employees get puny wages, Americans lose jobs and pay the same or more for the products. Gee, exactly who is winning with this arrangement? And then there is the matter of less regulation or pesky labor and environmental laws and probably tax benefits as well for American corporations. And speaking of taxex, where do you suppose the money to train whoever on safety measures comes from….. US tax dollars perhaps?

Herman report - Download MP3 (454K) audio clip
Listen to Herman report audio clip
India and the United States have agreed to work together to improve standards for food and drugs. VOA correspondent Steve Herman reports from New Delhi that the progress comes during a visit to India by the U.S. government official who oversees many of the agencies responsible for America’s health and safety standards.

Indian officials say New Delhi and Washington have agreed to form working groups to set standards for the import and export of medicine and food.

This comes after the United States signed two agreements with India’s economic rival, China - one concerning food, the other dealing with pharmaceuticals and medical equipment.

Both India and China have had problems with exports to the United States because health regulations and other standards were not being met.

Compared to other countries, India has the highest number of food products that are rejected as imports by the United States. Spices, seafood, fruit and additives have been especially troublesome in terms of high levels of bacteria or carcinogenic substances.

India also has a problem with widespread counterfeiting of prescription drugs.

Mike Leavitt The formation of the Indo-American working groups comes after meetings this week in India between U.S. Health and Human Services Secretary Mike Leavitt and his Indian counterparts.

Leavitt tells VOA News enhancing health standards for products moving across borders has become vital.

“We’re at the early stages of a global market that is now maturing and requiring new tools that haven’t existed in the past to handle the substantial volume of trade that is beginning to occur,” he explained. “These were important conversations and I expect, in time, we will see action - not just at the government level, but among private vendors as well.”

Leavitt was speaking Friday in New Delhi right after administering polio vaccination drops to children in a local slum area.

HHS Secretary Mike Leavitt administers polio vaccine drops to a child in New Delhi, 11 Jan 2008 Last year, the U.S. Department of Health and Human Services contributed $2.3 million to India’s efforts to eradicate polio.

Leavitt also announced Friday that the U.S. government is willing to provide technical assistance to help create an Indian version of the Food and Drug Administration. In the United States, the FDA is the federal agency responsible for ensuring the safety of food, pharmaceutical products, medical devices, cosmetics and certain electronic products.
By Steve Herman
New Delhi

Another Ticking Bomb

Posted in Public Affairs, Technology, Health, Terrorism, wordpress, United States, Safety, Public, Africa, EU, Big Pharma, Asia on November 7th, 2007 by Stanford Matthews

H5N1Avian flu may be the best example of a potential catastrophic event that will be largely ignored or shrouded with incompetence or sheer apathy right up until the moment it becomes a pandemic. While considerable focus and attention was placed on the topic early on, since then the tiny foe has systematically gone about its business with little opposition from any source capable of mounting a reasonable defense.

Not like there are no other major issues about which we should be concerned. However, avian influenza is a threat that can make all the others rather moot. It is the sort of problem that displays no discrimination or prejudice or other human attribute when selecting targets. Whatever can be defined as part of the biosphere is on its list of targets. No socio-economic or geopolitical considerations here. No personal preferences or bias or any other subjective analysis clouds its judgment. As a matter of fact, there is no judgment. It’s not that kind of arrangement.

Most people are aware that H5N1 is only advancing as slow and methodical as itbiotech has for lack of successful method to infect other species. There have also been reports that much progress has been made in developing vaccines. Reports in addition to the two presented here have suggested enough vaccine can be produced but there may be shortcomings attached to this solution. And of course, the early discussions made many comparisons to the 1918 flu epidemic as well as the frequency of such events and that we are overdue for another.

The primary point of this post is to publish another warning that there may be a serious lack of concern and response to the risk from this particular foe. The virus is extending the courtesy of giving the human species a great deal of time to solve the problem. But just like the fact that this living organism does not apply subjective analysis to its daily business, the time allowed thus far to prepare ourselves is simply the result of a natural sequence of events. If we end up not being prepared when the threat advances we will have no one to blame but ourselves.

Scientists Say Bird Flu Spreading in Several Asian, African Countries

By Luis Ramirez
Bangkok
07 November 2007

Ramirez report (MP3) - Download 900K audio clip
Listen to Ramirez report (MP3) audio clip

Nations in Asia and Africa have had much success in stopping the spread of bird flu, but experts meeting in Bangkok this week say the H5N1 virus continues to spread in a number of countries. VOA’s Luis Ramirez reports from Bangkok.

Experts with the U.N. Food and Agriculture Organization say bird flu is still considered an animal disease, affecting only a small number of humans so far. But they say the threat of a human pandemic, in which millions could die, is still very real.

Dr. David Nabarro, the United Nations’ senior Coordinator for Avian and Human Influenza, told reporters in Bangkok Wednesday that while most nations have made progress in containing the virus’ spread, there remain some problem areas.

“We’ve seen during the last three years that countries have invested a lot of resources in vaccination of poultry, in improving veterinary services, and also in what we call bio-security, in order to try to reduce the risk of…avian influenza continuing to circulate in poultry or in wild birds,” he said. “We’ve seen in many countries, extraordinary success in getting this under control: (but) not everywhere. There’s some problems in the region.”

He says the virus continues to spread in Bangladesh, Indonesia and Vietnam in Asia, and Egypt and Nigeria in Africa.

Experts say nations that have yet to develop an export-oriented poultry industry are finding it more difficult to contain the disease.

They say Thailand, as one example, has had greater success in controlling bird flu, because it already had a veterinary system in place to support its sizable poultry exports.

Another challenge that could hinder efforts to contain the spread of H5N1 is the reluctance by some countries to hand over tissue samples of bird flu cases. China is one of them. Dr. Nabarro says negotiations continue in efforts to get Beijing to disclose more data and materials that could help scientists develop a vaccine.

“There are some situations in which countries have asked for clarification on the benefits that they’re likely to get as a result of sharing samples, and there is some international negotiation under way at the moment to try to establish a satisfactory basis for sample-sharing by seeing whether or not it will be possible to ensure that those who do provide samples are able to benefit from products that are produced with the help of those samples,” he said.

Experts say Beijing’s concerns have to do with intellectual property rights to any vaccine that is developed with data or research originating in China. Indonesia has hesitated to supply tissue samples for similar reasons.

Representatives of several nations are scheduled to meet in Geneva later this month to address those concerns and talk about setting up a new international standard of sharing information and samples.

The H5N1 strain of the avian influenza virus mainly affects birds and has struck primarily in Asia, but it has also appeared in Europe and Africa. Since its appearance in Hong Kong in 1997, the H5N1 virus has killed at least 211 people in eleven countries. Tens of millions of poultry have died or been slaughtered due to the disease.

The World Health Organization says all evidence to date indicates that close contact with dead or sick birds is the principal source of human infection. Scientists say they are mainly concerned about the virus in animals for now, but fear that the virus could mutate and become easily transmissible between humans.

UN Expert Says World Unprepared for Avian Flu Pandemic

By Lisa Schlein
Geneva
24 October 2007

Schlein report (mp3) - Download 758k audio clip
Listen to Schlein report (mp3) audio clip

A top United Nations expert on Avian influenza says the world is not yet ready to protect itself from a potential avian influenza pandemic that could kill millions of people. He says it will take another few years before countries complete their pandemic preparedness plans. Lisa Schlein reports for VOA from Geneva.

Health experts are concerned that the deadly H5N1 bird flu virus will transform itself into the virus that causes the next human pandemic.

David Nabarro is senior U.N. systems coordinator for avian and human influenza. He says many uncertainties surround the disease. But, what is certain, he says, is that there will be a human influenza pandemic some time in the future.

He says no one knows when or where this will happen or how severe it will be. But, he says, given the potential magnitude of human suffering and of the economic consequences, it is essential to be prepared.

He says most countries have some kind of pandemic preparedness plan in the works.

“Unfortunately, only a relatively small proportion are adequately prepared to keep going in the event that the pandemic has massive absenteeism associated with it. And we need hard work for at least two or three years more to make sure that the whole world is properly pandemic ready. It is not easy. But, I will tell you one thing: being prepared for a pandemic will help countries to be prepared for other mega-catastrophes, not just those that are due to infectious disease,” said Dr. Nabarro.

The World Health Organization reports bird flu has spread to about 60 countries and territories. It says the H5N1 virus appears to be entrenched in the poultry populations of Indonesia, northern Egypt and parts of Nigeria, Bangladesh, China and Vietnam.

Bird flu remains a largely animal disease. But, latest figures show about 350 people who had close contact with diseased poultry have become infected and more than 200 have died.

Dr. Nabarro says health experts fear that one day H5N1 or another animal virus will mutate into a form that could spread easily from one human to another.

In anticipation of this, he says WHO is working with national authorities to make sure they will be able to respond promptly to contain the virus wherever it emerges.

“That prompt response has to be within days,” said Dr. Nabarro. “WHO has worked with countries to develop protocols for rapid response and has also been ensuring that there are adequate stockpiles of Oseltamivir or Tamiflu, which is part of the rapid response. WHO is also working on trying to ensure that there will be a plan that can be put into place for rapid production of pandemic vaccines once the new virus appears and also is looking at the possibility of vaccines against H5N1 in humans stockpiled.”

Dr. Nabarro says it will take drug companies about six months to manufacture vaccines against avian influenza once a pandemic appears and the viral strain is identified. He says millions of people could die during that period.

Should avian influenza strike, he says people should stay away from crowds. They should wear protective gear, such as masks and they should use the anti-viral drug Tamiflu.

No Campaign Solution for Health Care

Posted in Public Affairs, Money Matters, Health, wordpress, Politics, campaign, election, GOP, Democrats, News Media, Clinton, lobbyist, United States, Advertising, hillary, Big Pharma on September 18th, 2007 by Stanford Matthews

crossposted at:
Maggie’s Notebook | Conservative Blog

FaultlineUSA
Conservative Thoughts

issues that matter
Besides the title, the first sentence draws attention and interest in this AP report presented below. One can probably find plenty of examples of issues in this country being improperly handled. But health care is equally bizarre or absurd in the way it is mishandled coupled with the subtle but real consequences for this nation in the long term if we don’t soon approach it intelligently.

In Health Care Debate, U-Word Is Back

By NANCY BENAC Associated Press Writer
WASHINGTON Sep 16, 2007 (AP)

It’s been 14 years since first lady Hillary Rodham Clinton’s health care reform plan sank like a stone …

Hillary Rodham Clinton’s past failure with health care should not be her reason for addressing it again. If anyone including Hillary Rodham Clinton had a viable, broad solution capable of winning support from both parties, special interest and the general public that would be great. But this report and other common knowledge most people possess about these matters would indicate neither she nor anyone else will be bringing such a solution forward.

Democratic candidates argue it is the government’s job to make sure everyone has health insurance they cannot lose.
Dems‘Make sure’ means an unlimited supply of taxpayer money to pay for whatever politicians think will make them look good. By the time the truth of the failure is published in the press, the usual anonymous suspects will be guilty as charged. Like a quote from a recent PBS program, ‘everyone is guilty so no one’s to blame.’

Republicans are pushing more limited incentives and subsidies to help people obtain affordable coverage. Which will GOPresult in the same problem for different reasons than the Dems plan. Both political parties are missing the point on this issue. They both rely on government appropriations as the vehicle. This is an issue where we are all guilty but everyone is to blame. It is understandable that anyone who is satisfied with their current health care situation would be reluctant to change. But even those who are happy are at risk. The system cannot be supported by taxpayer funds forever and the costs will not decrease if we continue the way it is.

Both sides are trying to steer clear of anything resembling the 1993 plan.

A professor at Emory University named Kenneth Thorpe was involved with Clinton on her 1993 health care fiasco and has worked with her and the other Dems as well on their health care plans this time. So all the Democratic party candidates are offering a repackaged 1993 idea that failed. That is why the Harry and Louise ad depicted the fretting couple worried about the government running health care. No wonder, it has worked so well so far. The special interest money machine has molded the government program into a rubber stamp for pay as we say coverage. Why else would a ‘patient’ pay nothing for a motorized chair or Viagra or getting their stomach stapled? Both social security and Medicare are paying for all manner of things and people never originally intended to be on it. And some are surprised the golden goose is running out of money…… our money.

Clinton was described as ‘adamant’ that “we’re going to get it done this time.”

HRCHillary Rodham Clinton should choose her words more carefully. Who in their right mind would agree that politicians have gotten anything ‘done’ in the true sense of the word? Just look at a few examples of legislation in general. If you read the text of most bills you will find phrases like ‘to modify’, ‘change’ or in some way alter existing legislation. A bill is introduced and before it ever passes or fails it is swamped with amendments, lost in committee, languishing in some isolated outpost in Washington or being revised. Little gets ‘done’ in Washington. So please, Hillary Rodham Clinton, stop with the rhetorical nonsense, like suspension of disbelief. Which could have been used here to describe your statements.

The reason health care won’t get ‘done’ is that the issue already has been reduced in the politicians’ mindset to insurance coverage. The funny thing is Hillary Rodham Clinton was sliced and diced by the same insurance lobby that she has cozied up to since then. If you can’t beat ‘em, join ‘em. So what type of reform do you think Hillary Rodham Clinton will get for you? With the other Dems drinking the same tainted Kool Aid offered by the same authors this time around, their plans will be substantially the same thing. And the GOP’s sentiment is simply Hillary Lite.

Citizens who are currently satisfied even if that only means they have insurance but it is not adequate will not rock the boat for fear of things getting worse. Those who need or desperately need health care solutions will not be addressed or will decline to complain for all the good it will do. The politicians are either avoiding the mess or in the pockets of lobbyists and things have a better chance of getting worse for all consumers.

And we’ll all keep drinking, smoking and eating ourselves into oblivion while avoiding sufficient activity as we couch potato and yell at the news we don’t watch. There are those who will not exit the drug induced stupor or coma long enough to care or the infinite number of other high risk behaviors that helped get us here in the first place.

Patients will keep asking for popular meds that feed Big Pharma’s coffers. Doctors will keep prescribing them and too often not listen to what their patients are saying. Nurses will continue to claim doctors don’t save your life, nurses do and they might be right. But too many people will die in hospitals or other facilities for reasons defying logic. And TV news magazines will continue to warn us about the peril while their evening news broadcast partners are cluttered with ads for those popular drugs from Big Pharma with side effects appearing worse than the ailment they are intended to medicate.

The health care problem in this country is that no one, really, no one wants to address health care. At least not in any way that would truly solve it. Everyone offering a plan is expecting someone else to carry the load. In other words, go ahead and fix it as long as it does not inconvenience me or require any discipline or sacrifice on my part.

Stanford Matthews
MoreWhat.com

Trackposted to Pirate’s Cove, The Pink Flamingo, The Amboy Times, third world county, Republican National Convention Blog, Big Dog’s Weblog, Conservative Thoughts, Nuke’s News & Views, Rosemary\’s Thoughts, and The Yankee Sailor, thanks to Linkfest Haven Deluxe.

The ‘i’ in iPhone Stands for Idiot

Posted in Money Matters, Technology, Health, Education, wordpress, Microsoft, internet, Hol_ywood, Advertising, Video, Public, Net Neutrality, telecom, Sony, Nintendo, Entertainment, Business, Apple, Big Pharma on July 1st, 2007 by Stanford Matthews

The ‘i’ in iPhone stands for idiot. Consumers pay too much for everything and then at some point complain that prices are too high. Everything costs too much because you keep buying it at ridiculous prices. The business community doles out technology products and services, as well as others, in tiny incremental phases at bloated prices and minimal or substandard capability, performance, features, quality, etc., etc., and consumers keep flocking to each new marketing ploy. The ‘i’ in iPhone stands for idiot.

Think different except when you buyThe youngest among us are the easiest to fool. Haven’t been on the planet long enough or care about the trends that matter. Gotta have the newest and coolest even if it is a marketing campaign that defines the object. The trend is the business community has long known how to use hype to drive revenue. They not only target the younger demographic due to the extreme discretionary income as compared to other groups but they are keenly aware that they are largely clueless when it comes to intelligent purchasing decisions supported by fact.

As for the older demographic that follows suit, they once were part of the younger demographic that was clueless and no improvement in buying decisions has occurred over time. These two demographics are in large part responsible for the continued promotion of second rate products and services at unreasonable prices.

Why do houses cost so much? Because first time buyers only consider what they want and finding a way to qualify for a price they do not see as inflated. The mortgage industry is only too happy to invent flawed solutions like the subprime industry to accommodate such foolish transactions.

bring what you needWhy do cars cost so much? Why does health care cost so much? Why is the cost of an education higher than most think it should be? Although the details may vary the overall reasons for the cost of goods and services and their associated real value are so dramatically skewed. People convince themselves they need what they are buying and have no patience, discipline or any buyer sophistication adequate to the task. This is followed by subsequent complaints about how bad things are without the consumer accepting any guilt for the outcome. The ‘i’ in iPhone stands for idiot.

Stanford Matthews
MoreWhat.com

Trackposted to Outside the Beltway, Perri Nelson’s Website, The Virtuous Republic, Right Truth, Big Dog’s Weblog, Stuck On Stupid, Leaning Straight Up, The Amboy Times, Pursuing Holiness, CatSynth.com “catback” weekend, The Magical Rose Garden, third world county, Right Celebrity, Wake Up America, Woman Honor Thyself, stikNstein… has no mercy, Pirate’s Cove, Nuke’s news and views, The Pink Flamingo, Dumb Ox Daily News, Church and State, The Random Yak, A Blog For All, 123beta, DeMediacratic Nation, Jeanette’s Celebrity Corner, Webloggin, Cao’s Blog, , Conservative Cat, , Diary of the Mad Pigeon, Allie Is Wired, Walls of the City, The World According to Carl, Blue Star Chronicles, High Desert Wanderer, Gone Hollywood, and The Yankee Sailor, thanks to Linkfest Haven Deluxe.

Public Enemies

Posted in Public Affairs, Money Matters, Science, Technology, Health, Announcement, wordpress, Politics, GOP, Democrats, astroturfing, conspiracy, News Media, Clinton, lobbyist, disclosure, ethics, oversight, United States, Net Neutrality, hillary, Medicare, Edwards, Business, Big Pharma on June 30th, 2007 by Stanford Matthews

AdMedia Partners Advises Chandler Chicco in Acquisition by inVentiv Health

World’s largest independent healthcare specialist agency acquired by leading provider of commercialization services to global pharmaceutical and life sciences industries

NEW YORK, June 26 /PRNewswire/ — Chandler Chicco, a full-service, global healthcare public relations firm, announced its acquisition by inVentiv Health (NASDAQ: VTIV) , the leading provider of commercialization and complementary services to the global pharmaceutical and life sciences industries. AdMedia Partners (http://www.admediapartners.com/), a New York financial advisory firm specializing in mergers and acquisitions to the advertising and marketing services, media, and related interactive, online and information services businesses, represented Chandler Chicco in the acquisition.

“This transaction serves to show that public relations and public affairs are crucial components of healthcare communications to healthcare professionals, consumers and regulatory bodies,” says Phil Palazzo, a Managing Director at AdMedia Partners. “In 12 years Chandler Chicco has become the leader in healthcare communications, working on complex products and campaigns for many of the world’s largest pharmaceutical companies.”

Earlier today, inVentiv Health, Inc. announced that it has signed a definitive agreement to acquire Chandler Chicco Agency (CCA), the world’s largest privately-held healthcare public relations firm. CCA will operate within the inVentiv Communications division, which provides a full suite of integrated healthcare marketing and communications solutions.

Under the terms of the agreement, inVentiv will acquire CCA for $65 million in cash and stock, plus earn-out payments for exceeding specified financial targets. The transaction, which is subject to receipt of Hart-Scott-Rodino approval and other customary closing conditions, is expected to close in the third quarter. The acquisition is expected to be immediately accretive to inVentiv’s earnings.

Chandler Chicco Agency is a full-service, global healthcare public relations firm. Founded in 1995 by healthcare public relations veterans Robert Chandler and Gianfranco Chicco, CCA provides clients with insight-driven communications strategies that — through innovative and powerful programs — build, enhance or protect brand value and further public affairs agendas. The company’s client roster includes many of the world’s top pharmaceutical companies including Allergan, GlaxoSmithKline, and Novartis. For CCA, 2007 has been a banner year winning multiple awards — two awards from PR Week, Midsize Agency of the Year and Agency of the Year, and two awards from the Holmes Report, Specialty Agency of the Year and Healthcare Agency of the Year.

“In today’s competitive marketplace, our pharmaceutical clients are increasingly turning to public relations to build awareness, credibility and loyalty for their products,” said Eran Broshy, Chairman and CEO of inVentiv Health. “Chandler Chicco Agency has established an unmatched reputation in the healthcare PR industry that is distinguished by solid long-term client relationships and an impressive history of growth. Adding CCA to our portfolio of services will significantly expand our PR offering, while also broadening our global capabilities.”

CCA principal and co-founder Robert Chandler said, “Our successes over the past 12 years have been unprecedented and the next 12 will be, too, because we’re putting into place a smart global growth strategy that will lead us to even greater achievement.”

“This partnership allows us to scale up globally at warp speed and with greater authority, while maintaining our culture of success,” added Gianfranco Chicco, co-founder and CCA principal. “It is an ideal partnership.”

Upon the close of the transaction, CCA will become a wholly-owned subsidiary of inVentiv Health and operate within the inVentiv Communications division. The CCA brand and all the other brands that are part of the Chandler Chicco Companies, including Biosector2, BrandTectonics, CCA Advertising, Determinus, Litmus and ‘nition will remain, and Robert Chandler and Gianfranco Chicco will continue to lead the business, reporting into William O’Donnell, President and COO of inVentiv Communications.

Conference Call Details

inVentiv will host a conference call today, June 26, 2007, at 5:30pm EDT to discuss its acquisition of Chandler Chicco Agency. Call in number: 800-358-8448 (Domestic) or 706-634-1367 (International) Live and Archived Webcast: http://www.inventivhealth.com/

A replay of the call will be available immediately following the call through July 3, 2007 at 800-642-1687. The conference ID number for the replay is 4413978.

About Chandler Chicco Agency

Chandler Chicco Agency is the world’s largest independent healthcare specialist public relations agency with offices in New York, London, Washington D.C., Los Angeles and Paris. CCA offers strategic public relations and communications counsel to clients that include hospitals, NGOs, healthcare associations, coalitions and most of the world’s largest pharmaceutical companies. CCA is the flagship company for Chandler Chicco Companies; other brands under the Chandler Chicco Companies umbrella include Biosector2, BrandTectonics, CCA Advertising, Determinus, Litmus and ‘nition. For more information, visit http://www.ccapr.com/.

About inVentiv Health

inVentiv Health, Inc. (NASDAQ: VTIV) is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health currently works with over 200 unique pharmaceutical, biotech and life sciences clients, including all top 20 global pharmaceutical companies. For more information, visit http://www.inventivhealth.com/.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health’s performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

About AdMedia Partners

AdMedia Partners is a leading boutique financial advisory firm that provides middle market mergers and acquisitions advisory services to advertising and marketing services, media and publishing, and related Internet businesses. Founded in 1990 and located in New York City, the firm has completed over 150 transactions worth over $5 billion since 1999.

Select recent Marketing Services and Internet Marketing transactions completed by AdMedia Partners include:

* Representing Medical Broadcasting Company, one of the largest independent interactive healthcare agencies, in its acquisition by Digitas Inc.

* Representing Ignite Health, a leading interactive healthcare marketing agency, in its acquisition by inVentiv Health.

* Representing Addison Whitney, a full service brand identity and consulting firm that specializes in creating unique brand solutions for global pharmaceutical, biotechnology and medical companies, in its acquisition by inVentiv Health.

* Representing Public Strategies, a leading corporate communications firm, in its acquisition by WPP.

* Representing The Glover Park Group, a leading independent corporate communications and public affairs firm, in its sale to private equity firm Svoboda, Collins.

* Representing both New Media Strategies and Genex in their sales to Meredith.

* Representing CFM Direct, a leading direct marketing agency, in its acquisition by Merkle, a leading database marketing agency.

For more information, contact:

Phil Palazzo
Managing Director
ppalazzo@admediapartners.com

Greg Smith
Managing Director
gsmith@admediapartners.com

AdMedia Partners
444 Madison Avenue
New York, NY 10022
(212) 759-1870

Website: http://www.admediapartners.com/
Website: http://www.inventivhealth.com/
Website: http://www.ccapr.com/

Hillary Rodham Clinton: Foolin’ the Masses

Posted in Public Affairs, Health, wordpress, Politics, campaign, election, Democrats, liberal, astroturfing, Clinton, lobbyist, disclosure, ethics, Net Neutrality, hillary, Medicare, Big Pharma on June 29th, 2007 by Stanford Matthews

crossposted at:
Conservative Thoughts

Obama to Pass Clinton in Money Raised, Her Aide Says

Eager to cast its fundraising total for the second quarter in a positive light, the presidential campaign of Sen. Hillary Rodham Clinton (D-N.Y.) said it expects to report raising less than Sen. Barack Obama (D-Ill.), taking in about $27 million, roughly equivalent to what Clinton drew in the first…

Hillary Rodham ClintonPossibly more interesting than the fact the Queen of Cringe’s campaign announced she will be outdone in fund raising by the Obama campaign this quarter is the fact her Communications Director’s top resume item is crisis management. And it is funny that the Dems will not debate on Fox yet Howard Wolfson’s association with The Glover Park Group featured NewsCorp as a client. You know, Rupert Murdoch, NewsCorp, Fox News, Fox Broadcasting, etc. And the connections to Rupert Murdoch are just the beginning of Hillary Rodham Clintons’s contradiction in alliances. Glover Park Group has much to do with that.

Her Communications Director, Howard Wolfson, a New York native who started in politics working for his hometown Congresswoman Nita Lowey. He has worked for Chuck Schumer and Hillary Rodham Clinton before as well as the DCCC. But HRC’s association with Glover Park and the firm’s history in politics and business runs counter to Hillary Rodham Clinton’s contrived image, liberal appeal and strengthen claims of her dark side.

Campaign Contributors“She’s got a deeper bench of big money and corporate supporters than her competitors,” says Eli Attie, a former speechwriter to Vice President Al Gore. Not only is Hillary more reliant on large donations and corporate money than her Democratic rivals, but advisers in her inner circle are closely affiliated with unionbusters, GOP operatives, conservative media and other Democratic Party antagonists.

Dick Morris introduced the Clinton’s to a couple of pollsters named Doug Schoen and Mark Penn. Their firm, PSB, introduced to consulting the concept of “inoculation”: shielding corporations from scandal through clever advertising and marketing. Hillary Rodham Clinton has been associated with them ever since. But even Al Gore would not risk a continued relationship with Penn. He didn’t trust him and fired him during the 2000 campaign.

It is not that much different with Wolfson and principles and Hillary’s indifference to them. Glover Park’s clients have included standard liberal groups like the United Federation of Teachers and the ACLU. Yet the Clinton ties have also helped the firm make an alliance with Rupert Murdoch. Hillary started cozying up to Murdoch after her 2000 Senate victory, in a calculated attempt to defang his conservative media empire, News Corp. In 2004 the billionaire required a favor of his own: Nielsen was preparing to change the way it measured viewership in US TV markets, a plan that Murdoch’s Fox network feared would cost it millions in ad revenue. So Murdoch called on Glover Park. Wolfson secured a $200,000 contract and unveiled a PR blitz under the guise of a supposedly independent minority front group called Don’t Count Us Out.

The typical opposition research and tactics are not unfamiliar to Glover Park, Wolfson or Hillary Rodham Clinton as plenty of ‘bad news’, right or wrong, gets distributed to anyone interested in publishing it. Whether media outlets, bloggers or rivals of the target of the campaign.

Think about itThe not so subtle predictions that Hillary Rodham Clinton is the default Democratic candidate for 2008 is largely a product of people like Penn and Wolfson or others linked to the Clinton crew. Stay on message, cultivate the middle of the road liberal appearance, speak to the concerns of the Democratic base and lie your way to the White House.

Stanford Matthews
MoreWhat.com

Best Science News of the Week

Posted in Science, Technology, Health, Announcement, wordpress, ethics, United States, Stem Cell Research, Big Pharma, Japan on June 10th, 2007 by Stanford Matthews

Stem Cell Breakthrough Announced Amid Fierce Debate



07 June 2007
Bowman report - Download 697k audio clip
Listen to Bowman report audio clip

Scientists in the United States say they have for the first time been able to create stem cells from the ordinary skin cells of mice, a breakthrough that could lead to new medical breakthroughs and eliminate a contentious ethical and political debate over the use of human embryos for such research. From Washington, VOA’s Michael Bowman has more on the breakthrough.

stem cellsScientists say stem cells offer the promise of cures to everything from cancer to spinal cord injuries. Stem cells are malleable and can be used to create virtually any kind of tissue. But there has been a fierce ethical debate over stem cell research, because until now, it was assumed the cells had to be harvested from human embryos, destroying them in the process.

But teams in the United States, using a process pioneered by a leading Japanese researcher, say they have now successfully transformed skin cells from mice into what are, in effect, embryonic stem cells.

Biologist Rudolf Jaenisch at the Massachusetts Institute of Technology led one of the teams.

“We can take any skin cell and treat it in a certain way,” he said. “And after two or three weeks we will have embryonic stem cells which are indistinguishable from normal embryonic stem cells which have been derived from embryos.”

Could the same be done with human skin cells? No one knows just yet, or whether embryonic stem cells created in such a fashion would be as useful in research as those harvested from living embryos. Scientists say further study will be required, and that definitive answers may not be forthcoming for some time.

In the meantime, the political and ethical debate over embryonic stem cells continues to rage in the United States. Jaenisch says he is well aware of the political furor surrounding embryonic stem cell research, and cautions against injecting his findings with regard to mice into the current debate.

“Many who are opposed to embryonic stem cell research will use this [breakthrough] and say, ‘Ha! We do not need it [to use embryos].’ This is the wrong conclusion,” he said.

Meanwhile, in the U.S. Congress there has been more contentious debate on legislation to allow more federal funding for embryonic stem cell research, legislation that President Bush has said he will veto.

Before Thursday’s vote to send the measure to the president’s desk, Indiana Republican Mike Pence stood in opposition.

“Congress is once again poised to pass legislation that authorizes the use of federal tax dollars to fund the destruction of human embryos for scientific research,” he said. “I believe that life begins at conception. It is morally wrong to create human life to destroy it.

California Democrat Lynn Woolsey has a different point of view, stressing the seemingly limitless potential of stem cells to improve human health.

“How can we tell a parent watching a child suffering from cancer that we are not going to do every single thing possible to save that child? How can we tell a teenager that there is a chance we could repair a damaged spinal chord, but we are not going to pursue it,” she asked.

President Bush has authorized federal funds for stem cell research involving a small number of stem cell lines from discarded embryos. U.S. researchers say those lines are badly contaminated and of little scientific value, and that the United States is falling behind other nations with few restrictions on such research.

(source: voanews.com)

Breakthrough may end stem cell debate

Posted in Science, Technology, Health, wordpress, ethics, Stem Cell Research, Big Pharma on June 8th, 2007 by Stanford Matthews

stem cellsThere is no reason to get overly excited and there is equally no reason to despair. The caution on this great news is like any other discovery. There will be no solutions provided by this advance any time soon. The good news is this finding may end the ethical challenge about stem cell research much sooner than previously anticipated.

The short version is it is possible to convert something as basic as a skin cell into a stem cell with the same qualities as that of embryonic stem cells. That is, being able to generate any cells in the body. The current problem was only embryonic stem cells could do this and adult stem cells were already fixed and not nearly as useful for providing the desired medical solutions.

The conversion of ‘regular’ stem cells to those that can mimic the embryonic variety has only been done on mice. And the problem now is finding another way to make the conversion and do it for humans. The current method causes cancer in the mice. Not something that is desired in a medical solution. But this is good news and raises optimism that the holy grail of stem cell research may be on the horizon without the ethical problems.

Stanford Matthews
MoerWhat.com

Breakthrough may end stem cell debate

igh Dayton, Science Writer
June 07, 2007
INTERNATIONAL scientists have reported findings that promise to end the ethical row over stem cell research once and for all.

Separate teams of US and Japanese experts turned ordinary mouse tissue cells into fully functioning embryonic stems (ES) cells without the use of eggs or embryos, the most controversial aspect of ES cell research.

The findings - reported in the journals Nature and Cell Stem Cell - have been hailed as a genuine breakthrough.

“It’s just terrific. It allows us to really move forward,” said stem cell scientist Megan Munsie, director of scientific affairs and policy at the Australian Stem Cell Centre in Melbourne.

Sen Chuck Grassley: Beating a Dead Horse

Posted in Public Affairs, Money Matters, Health, wordpress, Medicare, Grassley, Business, Big Pharma, Legislation on May 7th, 2007 by Stanford Matthews

Sen Chuck GrassleyDo you suppose it is possible that Chuck Grassley and friends are missing the point? Prescription drug prices are merely one symptom of a health care system that is totally out of control. Another major symptom is the refusal of Congress to deal effectively with this problem.

From public and private sector components of the medical industry, including health insurance and medicare, to the legislature and the consuming public, we have it all wrong. Every facet of this issue is littered with no responsibility for the financial structure of providing health care. Providers are often unaware or unable to determine what to charge for services to break even. Consumers rely on insurance to cover the bulk of the cost. The government is complicit by adding to the pass the buck mentality on who pays for what. The system is so convoluted and drowning in regulations and paperwork it is ripe for fraud and abuse.

Health CareIn other words Mr Grassley, your support of importing drugs from other countries solves nothing. There is no real competition or incentive for it in the health care system. And even if you were lucky enough to lower some prices it would not be universal nor would it affect the price of health care services. Even before the failed Clinton Administration health care reform, no one in Washington is interested in real health care reform. It is all smoke and mirrors and political rhetoric. Get a grip and do something real about health care or simply stop talking about something you will never fix.

C. Harris
MoreWhat.com

May 1st, 2007

GRASSLEY: IT SHOULD BE LEGAL TO BUY CHEAPER PRESCRIPTION DRUGS FROM OTHER

COUNTRIESSenator sponsors amendment to ensure timely access to safe, lower-priced pharmaceuticals

WASHINGTON — Sen. Chuck Grassley, Ranking Member of the Committee on Finance, today joined in proposing an amendment that would make it legal for U.S. consumers to buy safe prescription drugs from other countries.

The legislation was filed as an amendment to the Food and Drug Administration Revitalization Act that is under consideration this week by the U.S. Senate. Grassley sponsored the measure with Sens. Byron Dorgan and Olympia Snowe.

Why Americans Should Be Able to Import Drugs

(Sen. Chuck Grassley)
May 4th, 2007

Making it legal for Americans to import their prescription drugs is a top priority at the grass roots. It needs to be a top priority here in Washington. I have long advocated allowing American consumers access to safe drugs from other countries.

Speaker Pelosi and Your Money

Posted in Science, Technology, Announcement, wordpress, Democrats, Pelosi, Congress, Business, Big Pharma on May 3rd, 2007 by Stanford Matthews

The following is a quote from a press release at Speaker Nancy Pelosi’s website:

“An enhanced federal investment in long-term basic research is crucial to future innovations and America’s overall competitiveness. Basic research serves as the building blocks of technological advancement, but because it doesn’t always directly lead to the creation of new products and services, private funding for basic research is not a priority. That is where the federal government must step in to ensure that basic research is adequately funded so that it continues to strengthen the foundation of innovation.

Speaker Pelosi and Your MoneySpeaker Pelosi, would you be so kind as to explain in more detail the relationship between publicly funded research, privately funded research, business and government? The reason for this request is simple to understand. If, as you stated, basic research is a low priority for private funding, why should it be subsidized by taxpayer funds? Is it because the private funding sources know they will get the successful research for free?

Is it possible that the burden of paying for technological innovation is almost exclusively shouldered by the public? When marketing new innovations, businesses like Big Pharma justify high prices as the immense cost of research. The public is forced to pay excessive prices on health care solutions. Taxpayer funding for research that is more likely to fail than succeed means the consumer may be cheated twice. Once by the government and later by the private sector when they get the research results and market another product. If much of this funding is funneled to universities and other public institutions, its main benefit may be providing income for researchers and not a benefit in the public interest.

The point is, Speaker Pelosi, that proclamations on wonderful ideas for spending taxpayer money should be supported by facts that allow the public to respond to your proposals objectively and not on hype.

Stanford Matthews
MoreWhat.com

Senator Snowe on Stem Cell Research

Posted in Science, Technology, Health, wordpress, Congress, Business, Big Pharma, Legislation on April 12th, 2007 by Stanford Matthews

AMAHope for millions is a recurring theme when discussing solutions and their timetables. Apparently, Senator Snowe is taking this opportunity to praise herself and/or her colleagues for passing stem cell legislation that has a low probability of becoming law without the votes to override the President’s veto pen. But hey, if you are going to get criticized for being pathetically ineffective, you might as well take the opportunity to pat yourself on the back to even it out some.

Hope for Millions Found in Stem Cell Bill

April 11th, 2007
This legislation provides a great hope to millions of Americans — and quite frankly, their families and caregivers — who suffer from a multitude of devastating diseases that have shown such great promise of being alleviated or cured through advanced stem cell research.
By Maine GOP Sen. Olympia Snowe

Senator Snowe is so bipartisan she has even taken to using a favorite four letter word of the Democrats. That would be the word ‘hope’. The Dems love that word. When you absolutely, positively are doing nothing for your constituents, sell them on the word hope. It makes one sound so humane and caring.

Big PharmaWith the ability to patent nearly everything including discoveries from the genome project, by the time any stem cell research results are ready for prime time, the only way Big Pharma will ever allow a cure to be distributed is if they own the patent. That way the drug that was rendered obsolete by the cure from stem cell research will allow them to continue ripping off the public and deciding who gets cure and who does not. And don’t even think for a New York minute that this is a wild conspiracy theory.

The idea that we could use our own cells to create a cure for what ails us is a magnificent proposition. Whether stem cell research is that holy grail or brass ring of medicine is unknown. When before in history has this country raged over a debate on something they don’t even know for sure is possible? The theoretical promise of stem cell research is a good thing. Like many topics the facts may be elusive making informed comment difficult. But like nearly everything else in the public sphere, much of the population is polarized on this issue as well. Perhaps we need more valid objective data to settle the dispute. But Senator Snowe, please, enough with the ‘H’ word.

Stanford Matthews
MoreWhat.com

Hillary Rodham Clinton, Vilsack and Healthcare

Posted in Health, wordpress, Politics, campaign, Clinton, hillary, Big Pharma on March 26th, 2007 by Stanford Matthews

These two stories may tell us two things. Vilsack will settle for Vice President rather than try at all to mount a campaign of his own or simply understand it’s time to go home. The chances for universal healthcare have just diminished now that Hillary Rodham Clinton is talking about it. Yes, she learned a lot with her husband’s failed healthcare policies. That she or her husband have no idea how to get significant legislation through Congress.

C. Harris
MoreWhat.com

Vilsack Joins Team Clinton

VilsackWashington Post -
David Yepsen, the most influential political reporter in Iowa, made that point in a column last Friday. “Endorsement politics mean little in Iowa, especially in presidential races, where caucus-goers are notorious for making up their own minds about …


Clinton Touts Universal Health Care Plan

Hillary Rodham ClintonWashington Post -
By MIKE GLOVER. AP. DES MOINES, Iowa — Saying she “learned a lot” during the failed health care effort of her husband’s presidency, Democratic presidential hopeful Hillary Rodham Clinton vowed Monday to create a universal health care system if elected